(Q36235496)

12 August 2017

1 reference

title

Risk of skin reactions when using ibuprofen-based medicines (English)

1 reference

12 August 2017

Mario Sánchez-Borges

1

1 reference

12 August 2017

Arnaldo Capriles-Hulett

series ordinal

2

1 reference

12 August 2017

Fernan Caballero-Fonseca

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

Expert Opinion on Drug Safety

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

837-848

1 reference

Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Epidemiology of drug allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Delayed Drug Hypersensitivity Reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Self-reported drug allergy in a general adult Portuguese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

NSAID-induced urticaria and angioedema: a reappraisal of its clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Rates of sensitivity reactions to aspirin: problems in interpreting the data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Adverse reactions to selective cyclooxygenase-2 inhibitors (coxibs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Tolerability of nimesulide and paracetamol in patients with NSAID-induced urticaria/angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

A case of anaphylaxis due to ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Failure of zafirlukast to prevent ibuprofen-induced anaphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Ibuprofen-induced, transient ANA- and anti-histone positive leukocytoclastic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Photosensitization caused by ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Drugs causing fixed eruptions: a study of 450 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Five cases of livedo-like dermatitis (Nicolau's syndrome) due to bismuth salts and various other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Generalized lichenoid drug eruption following Blaschko lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Delayed-type hypersensitivity rash from ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Drug-induced bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

The safety of acetaminophen and ibuprofen among children younger than two years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

Allergic reactions due to ibuprofen in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.837

21 January 2018

Identifiers

DOI

10.1517/14740338.4.5.837

1 reference

release_rnfahpfwkbdtlh3lmagomaazrq

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rnfahpfwkbdtlh3lmagomaazrq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference